drugset / Trial / NCT01728298
A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the trial is to evaluate the dose-response relationship with regards to change in immunological parameters and safety for SLITone ULTRA house dust mite mix in adult subjects with moderate to severe HDM allergic rhinitis.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SLITone ULTRA HDM immunotherapy | Unknown | — | — |